Invitrogen™ Human CRACC ELISA Kit

Ref.: BL-RE-092891Manufacturer ref.: EH126RBX5 5 x 96 tests
€2,950.00 excl. VAT

Human CRACC quantitates human CRACC in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CRACC.

Accession number
19 A ; 19A24 ; protéine 19A24 ; 4930560D03Rik ; sous-ensemble CD2 1 ; Récepteurs de type CD2 activant les cellules cytotoxiques ; cellules cytotoxiques de type CD2 activant les récepteurs ; CD319 ; CRACC ; CS1 ; antigène de surface cellulaire des leucocytes ; Protéine membranaire FOAP-12 ; Novel Ly9 ; nouvelle protéine similaire à l’antigène lymphocytaire 9 ; protéine 19 A ; RGD1560190 ; membre de la famille SLAM 7 ; Slamf7 ; UNQ576/PRO1138
Dose range
0.83 to 200 ng/mL
Sensitivity of the dosage
0.83 ng/mL
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Human CRACC quantitates human CRACC in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CRACC.

Human CRACC quantitates human CRACC in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant human CRACC.

SLAMF7 contains a C2 domain of d-Ig (immunoglobulins). L-isoform 1 allows the activation of NK cells via an ERK controlled emission pathway by an independent SAP extracellular signal. It can play a role in lymphocyte adhesion. L-isoform 3 does not provide any activation mediation. SAP may bind the cytoplasmic tail of l-isoform 1 when it is phosphorylated in the presence of Fyn (in vitro). SLAMF7 is expressed in spleen, lymph nodes, peripheral blood leukocytes, bone marrow, small intestine, stomach, appendix, lung and trachea. The expression was detected in NK cells, activated B cells, NK cell line, but not in promyelocyte, B-, or T cell lines. L-isoform 3 is expressed at a much lower level than l-isoform 1. There are three designated isoforms.

Sensitivity

Sensitivity of dosage: 0.83 ng/mL.

Measurement range

Dose range: 0.83 to 200 ng/mL.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: CRACC (CD319).

Samples

Type of sample: Plasma, Serum, Surnatant (plasma volume, 50 µl; Serum, 50 µl; Supernatant, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17194869
Specifications
Accession number19 A; 19A24; protein 19A24; 4930560D03Rik; CD2 sub-assembly 1 ; CD2 type receptors activating cytotoxic cells; CD2 type cytotoxic cells activating receptors; CD319; CRACC; CS1; cell surface antigen of leukocytes; Membrane protein FOAP-12; Novel Ly9
Dose range0.83 to 200 ng/mL
Sensitivity of the dosage0.83 ng/mL
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Genetic identification (Enter)Q9NQ25
Gene symbol(s)SLAMF7
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kitsPre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity5 x 96 tests
Regulatory statusUse exclusively for research
TargetCRACC (CD319)
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 µl; Serum, 50 µl; Supernatant, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.EH126RBX5
Country of originUnited States
A question or a specific configuration?
Contact us for a quote.